Optimizing Orthotopic Bladder Tumor Implantation in a Syngeneic Mouse Model

Journal of Urology

Volumn 182, Issue 6, 2009, Pages 2926-2931

  Chan, Eddie S Y ^a   Patel, Amit R ^b   Smith, Armine K ^b   Klein, John B ^b   Thomas, Anil A ^b   Heston, Warren D ^b   Larchian, William A ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

animal; models; polylysine; trypsin; urinary bladder; urinary bladder neoplasms

Indexed keywords

CHLORIDE; PHOSPHATE BUFFERED SALINE; POLYLYSINE; TRYPSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; BLADDER TUMOR; CANCER CELL; CANCER TRANSPLANTATION; CONTROLLED STUDY; CYSTITIS; DEATH; HEMATURIA; HISTOPATHOLOGY; MORTALITY; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RELIABILITY; TREATMENT DURATION; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME; ULTRASOUND;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; URINARY BLADDER NEOPLASMS;

EID: 72149100721     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.08.020     Document Type: Article

References (24)

1. Ratliff T.L. Role of animal models in understanding intravesical therapy with bacille Calmette-Guerin. Clin Infect Dis, suppl. 31 (2000) S106
2. McCue P.A., Gomella L.G., Veltri R.W., et al. Development of secondary structure, growth characteristics and cytogenetic analysis of human transitional cell carcinoma xenografts in scid/scid mice. J Urol 155 (1996) 1128
3. Soloway M.S. Intravesical and systemic chemotherapy of murine bladder cancer. Cancer Res 37 (1977) 2918
4. Summerhayes I.C., and Franks L.M. Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro. J Natl Cancer Inst 62 (1979) 1017
5. Moltedo B., Faunes F., Haussmann D., et al. Immunotherapeutic effect of Concholepas hemocyanin in the murine bladder cancer model: evidence for conserved antitumor properties among hemocyanins. J Urol 176 (2006) 2690
6. Satoh H., Morimoto Y., Arai T., et al. Intravesical ultrasonography for tumor staging in an orthotopically implanted rat model of bladder cancer. J Urol 177 (2007) 1169
7. Shapiro A., Kelley D.R., Oakley D.M., et al. Technical factors affecting the reproducibility of intravesical mouse bladder tumor implantation during therapy with bacillus Calmette-Guerin. Cancer Res 44 (1984) 3051
8. Horinaga M., Harsch K.M., Fukuyama R., et al. Intravesical interleukin-12 gene therapy in an orthotopic bladder cancer model. Urology 66 (2005) 461
9. Smith E.B., Schwartz M., Kawamoto H., et al. Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder. J Urol 177 (2007) 2347
10. Kohno S., Luo C., Goshima F., et al. Herpes simplex virus type 1 mutant HF10 oncolytic viral therapy for bladder cancer. Urology 66 (2005) 1116
11. Werthman P.E., Drazan K.E., Rosenthal J.T., et al. Adenoviral-p53 gene transfer to orthotopic and peritoneal murine bladder cancer. J Urol 155 (1996) 753
12. Sindhwani P., Hampton J.A., Baig M.M., et al. Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice. J Urol 166 (2001) 1498
13. Watanabe T., Shinohara N., Sazawa A., et al. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies. Cancer Gene Ther 7 (2000) 1575
14. Yu D.S., Lee C.F., and Chang S.Y. Immunotherapy for orthotopic murine bladder cancer using bacillus Calmette-Guerin recombinant protein Mpt-64. J Urol 177 (2007) 738
15. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71
16. Liu H., Schwartz M.J., Hwang D.H., et al. Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma. BJU Int 101 (2008) 894
17. Hadaschik B.A., Black P.C., Sea J.C., et al. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging. BJU Int 100 (2007) 1377
18. Soloway M.S., and Masters S. Urothelial susceptibility to tumor cell implantation: influence of cauterization. Cancer 46 (1980) 1158
19. Jurczok A., Fornara P., and Soling A. Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo: a new approach to optimize a syngeneic, orthotopic, murine bladder cancer model. BJU Int 101 (2008) 120
20. Gunther J.H., Jurczok A., Wulf T., et al. Optimizing syngeneic orthotopic murine bladder cancer (MB49). Cancer Res 59 (1999) 2834
21. Ahlering T.E., Dubeau L., and Jones P.A. A new in vivo model to study invasion and metastasis of human bladder carcinoma. Cancer Res 47 (1987) 6660
22. Siemens D.R., Austin J.C., See W.A., et al. Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium. J Urol 165 (2001) 667
23. Sylvester R.J., van der Meijden A.P., Oosterlinck W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49 (2006) 466
24. Jones T.D., Wang M., Eble J.N., et al. Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res 11 (2005) 6512